As a licensing factor, AR must be degraded during mitosis in order to allow DNA replication to reinitiate for subsequent cell cycling, with AR stabilization during mitosis inhibiting prostate cancer proliferation [5]. This evidence concerns the gene AR and prostate carcinoma.